Case reportPublished 29 Aug 2017
Successful Treatment of Adult-Onset Dermatitis Herpetiformis with Low Dose Naltrexone
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Dermatitis herpetiformis can be refractory to a gluten free diet in up to 2% of patients. A celiac disease patient with diet refractory dermatitis herpetiformis was treated with low dose naltrexone. Randomized controlled trials showed that this short acting opioid antagonist is effective therapy in Crohn’s disease and fibromyalgia. The patient’s skin lesions were present for 2 years and went into complete remission within 3 months of taking naltrexone. We theorize that gluten-associated antigens activate long-lasting memory B-lymphocyte cells that produce autoimmune antibodies and this may perpetuate dermatitis herpetiformis. Endorphins produced via up-regulation by low dose naltrexone may reduce this B-cell activity.
Subjects
General & Internal MedicineAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical and Medical Case Studies
- SubjectGeneral & Internal Medicine
- BylineArticles whose byline prints “Weinstock LB”
- BylineArticles whose byline prints “Myers TL”
- BylineArticles whose byline prints “Steinhoff M”
- BylineArticles whose byline prints “Smith JP”